Osaic Holdings’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-103
| Closed | -$2.98K | – | 7972 |
|
|
2025
Q4 | $2.98K | Sell |
103
-2,500
| -96% | -$47.5K | ﹤0.01% | 6946 |
|
|
2025
Q3 | $1.48K | Buy |
2,603
+2,499
| +2,403% | +$18.8K | ﹤0.01% | 7231 |
|
|
2025
Q2 | $754 | Sell |
104
-29
| -22% | -$255 | ﹤0.01% | 7243 |
|
|
2025
Q1 | $1.13K | Sell |
133
-4
| -3% | -$62 | ﹤0.01% | 6781 |
|
|
2024
Q4 | $4.91K | Hold |
137
| – | – | ﹤0.01% | 6203 |
|
|
2024
Q3 | $6.49K | Sell |
137
-2
| -1% | -$88 | ﹤0.01% | 6086 |
|
|
2024
Q2 | $6.99K | Sell |
139
-12
| -8% | -$868 | ﹤0.01% | 6007 |
|
|
2024
Q1 | $16.9K | Sell |
151
-2
| -1% | -$199 | ﹤0.01% | 5466 |
|
|
2023
Q4 | $8.89K | Sell |
153
-4
| -3% | -$161 | ﹤0.01% | 5896 |
|
|
2023
Q3 | $4.98K | Buy |
157
+28
| +22% | +$1.33K | ﹤0.01% | 6274 |
|
|
2023
Q2 | $10.6K | Hold |
129
| – | – | ﹤0.01% | 5923 |
|
|
2023
Q1 | $13.3K | Hold |
129
| – | – | ﹤0.01% | 5811 |
|
|
2022
Q4 | $19K | Hold |
129
| – | – | ﹤0.01% | 5602 |
|
|
2022
Q3 | $22K | Hold |
129
| – | – | ﹤0.01% | 5515 |
|
|
2022
Q2 | $15K | Buy |
129
+4
| +3% | +$376 | ﹤0.01% | 5811 |
|
|
2022
Q1 | $12K | Buy |
125
+90
| +257% | +$10.5K | ﹤0.01% | 6029 |
|
|
2021
Q4 | $5K | Hold |
35
| – | – | ﹤0.01% | 6639 |
|
|
2021
Q3 | $8K | Buy |
35
+2
| +6% | +$584 | ﹤0.01% | 6332 |
|
|
2021
Q2 | $11K | Buy |
33
+22
| +200% | +$8.33K | ﹤0.01% | 6004 |
|
|
2021
Q1 | $5K | Buy |
11
+9
| +450% | +$4.37K | ﹤0.01% | 6161 |
|
|
2020
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 6238 |
|
|
2020
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 6039 |
|
|
2020
Q2 | $1K | Sell |
2
-16
| -89% | -$5.46K | ﹤0.01% | 5961 |
|
|
2020
Q1 | $3K | Buy |
+18
| New | +$3.15K | ﹤0.01% | 5550 |
|
Other funds holding MRSN
Osaic Holdings's MRSN Position: Q1 2026 in Review
Osaic Holdings sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 103 shares — an estimated $2.98K sold.
Osaic Holdings first reported a position in MRSN in Q1 2020 and held it in 24 quarters. The position peaked at $22K in Q3 2022. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.
- Osaic Holdings reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
- Osaic Holdings sold 103 Mersana Therapeutics shares in Q1 2026, an estimated $2.98K.
- Osaic Holdings first reported a position in Mersana Therapeutics in Q1 2020 and held it in 24 quarters.
- Osaic Holdings's Mersana Therapeutics position peaked at $22K in Q3 2022.
- 1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.